Table 1 Hematological parameters that demonstrated significant difference based on the age and sex of TB patients before initiation of anti-TB drugs compared with after completion of the intensive phase of treatment

4.27 ± 0.92

4.43 ± 0.92

4.24 ± 0.72

4.42 ± 0.68

4.26 ± 0.77

4.42 ± 0.89

4.37 ± 0.75

4.33 ± 0.68

4.09 ± 1.01

4.58 ± 0.92

12.7 ± 2.1

11.8 ± 1.5

12.8 ± 2.1

11.8 ± 1.9

12.9 ± 2

11.8 ± 1.8

12.9 ± 1.8

12 ± 1.4

12.4 ± 2.5

11.5 ± 1.8

38.6 ± 6

35.8 ± 4.4

38.9 ± 5.5

35.7 ± 5.4

39.1 ± 5.7

35.7 ± 5.5

38.9 ± 4.9

36.6 ± 4

37.9 ± 6.8

34.7 ± 5

88.4 ± 6.9

89.4 ± 9.1

89.4 ± 6.7

90.9 ± 5.1

89.4 ± 7.3

90.2 ± 5.1

88.3 ± 5.8

91.2 ± 5.8

88.7 ± 7.6

90.4 ± 5.2

28.9 ± 3.3

29.6 ± 2.3

29.2 ± 2.6

30.1 ± 2

29.3 ± 3

29.7 ± 2.1

29.1 ± 3.1

29.7 ± 2.5

28.5 ± 3

30 ± 2

32.7 ± 2

32.7 ± 1.3

32.6 ± 1.4

33.1 ± 1.1

32.6 ± 1.6

32.9 ± 1.3

33 ± 1.9

32.7 ± 1.3

32.2 ± 1.6

33.1 ± 1

14.4 ± 1.4

14.2 ± 1.2

14.5 ± 1.7

13.9 ± 1.2

14.4 ± 1.4

14.1 ± 1.3

14.3 ± 1.4

14.1 ± 1.2

14.6 ± 1.8

14 ± 1.1

267 ± 106

232 ± 109

270 ± 101

250 ± 86

258 ± 105

250 ± 116

274 ± 101

246 ± 72

275 ± 105

216 ± 108